Downregulation of DOCK1 sensitizes bladder cancer cells to cisplatin through preventing epithelial–mesenchymal transition

During the past several decades, resistance to single or multiple anticancer agents has posed a great challenge in cancer therapy. Dedicator of cytokinesis 1 (DOCK1), the first identified member in DOCK family, plays diverse roles in cellular processes, including tumorigenesis. In this study, we exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Da-jin, Chen, Wei, Jiang, Hong, Yang, Hao, Wang, Yu-cheng, Chen, Jiang-hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019270/
https://www.ncbi.nlm.nih.gov/pubmed/27660415
http://dx.doi.org/10.2147/DDDT.S101998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019270/
https://www.ncbi.nlm.nih.gov/pubmed/27660415
http://dx.doi.org/10.2147/DDDT.S101998

Ejemplares similares